Article Listing - Strong relapse data for Biogen Idec's Avonex

FRENCH HEALTH SPENDING RISE

13 April 1992

French health care spending by the CNAM insurance fund rose 0.3% between December 1991 and January 1992. Spending in January...

STOCK MARKET COMMENTARY: NEW YORK

13 April 1992

NEW YORK: stock prices climbed throughout nearly the whole rep-orting week, closing with a 40-point or 1.2% rise, following slow...

US NEW PRESCRIPTI0N DRUG SALES IN 1991

13 April 1992

The leading new prescription pharmaceutical product in the USA last year was Wyeth-Ayerst's non-steroidal anti-inflammatory drug Lodine (etodolac), which received...

ROCHE CONSOLIDATED PROFIT LEAPS 56% IN 1991

13 April 1992

For 1991, Swiss pharmaceutical major Hoffmann-La Roche reported "continued and significant improvement in the group's earning performance," with consolidated group...

SCHWARZ PHARMA MAKES STRIDES IN EAST GERMANY

13 April 1992

The medium-sized German drugmaker Schwarz Pharma AG has criticized the 25% discount regulation applying to eastern German drugs sales. Board...

ORGANON LAUNCHES PHYSIOGINE IN FRANCE

13 April 1992

Organon has launched Physiogine (estriol), in 0.1% vaginal cream and 0.5mg capsule formulations for the local treatment of post-menopausal symptoms,...

HAFSLUND GOES FOR ITALIAN MARKET

13 April 1992

The Norwegian pharmaceutical and diagnostics company Hafslund Nycomed has started operations in Italy through its Milan-based subsidiary, and is about...